Home/Filings/4/0001209191-22-054196
4//SEC Filing

Marek David C 4

Accession 0001209191-22-054196

CIK 0001679082other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 4:53 PM ET

Size

4.8 KB

Accession

0001209191-22-054196

Insider Transaction Report

Form 4
Period: 2022-10-18
Marek David C
DirectorPrincipal Executive Officer
Transactions
  • Sale

    Common Shares

    2022-10-18$25.20/sh11,156$281,131425,636 total
Footnotes (1)
  • [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.

Issuer

Myovant Sciences Ltd.

CIK 0001679082

Entity typeother

Related Parties

1
  • filerCIK 0001556914

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:53 PM ET
Size
4.8 KB